The Present Study Will Include A Population Of Patients With Established Attr Cm clinical trials

Explore recruiting the present study will include a population of patients with established attr cm clinical trials.

Also recruiting in Europe

The Present Study Will Include A Population Of Patients With Established Attr Cm trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy and safety of NNC6019-0001 at two dose levels in participants with transthyretin amyloid cardiomyopathy (ATTR CM).

Portugal, Netherlands, Germany, Spain, Czechia, Italy +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

The Present Study Will Include A Population Of Patients With Established Attr Cm trials by city

The Present Study Will Include A Population Of Patients With Established Attr Cm in Toronto The Present Study Will Include A Population Of Patients With Established Attr Cm in Vancouver The Present Study Will Include A Population Of Patients With Established Attr Cm in Montreal The Present Study Will Include A Population Of Patients With Established Attr Cm in Calgary The Present Study Will Include A Population Of Patients With Established Attr Cm in Edmonton The Present Study Will Include A Population Of Patients With Established Attr Cm in Ottawa The Present Study Will Include A Population Of Patients With Established Attr Cm in Winnipeg The Present Study Will Include A Population Of Patients With Established Attr Cm in Quebec City The Present Study Will Include A Population Of Patients With Established Attr Cm in Hamilton The Present Study Will Include A Population Of Patients With Established Attr Cm in Kitchener The Present Study Will Include A Population Of Patients With Established Attr Cm in London The Present Study Will Include A Population Of Patients With Established Attr Cm in Halifax The Present Study Will Include A Population Of Patients With Established Attr Cm in New York The Present Study Will Include A Population Of Patients With Established Attr Cm in Los Angeles The Present Study Will Include A Population Of Patients With Established Attr Cm in Chicago The Present Study Will Include A Population Of Patients With Established Attr Cm in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease